المؤلفون: Martin-Broto J; Corresponding Author: Javier Martin-Broto, Department of Oncology, University Hospital Son Espases, Cra Valdemosa 79, 07010 (Office 144, 1H), Palma de Mallorca, Spain. javier.martin@ssib.es., Gutierrez AM, Ramos RF, Lopez-Guerrero JA, Ferrari S, Stacchiotti S, Picci P, Calabuig S, Collini P, Gambarotti M, Bague S, Dei Tos AP, Palassini E, Luna P, Cruz J, Cubedo R, Martinez-Trufero J, Poveda A, Casali PG, Fernandez-Serra A, Lopez-Pousa A, Gronchi A

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2014 Jan; Vol. 13 (1), pp. 249-59. Date of Electronic Publication: 2013 Oct 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: ATP Binding Cassette Transporter, Subfamily B, Member 1/*biosynthesis , Glutathione Transferase/*biosynthesis , Multidrug Resistance-Associated Proteins/*biosynthesis , Neoplasm Recurrence, Local/*genetics , Sarcoma/*genetics, ATP Binding Cassette Transporter, Subfamily B ; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; Aged ; Anthracyclines/administration & dosage ; Disease-Free Survival ; Drug Resistance, Multiple/genetics ; Extremities/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Glutathione Transferase/genetics ; Humans ; Male ; Middle Aged ; Multidrug Resistance-Associated Proteins/genetics ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Sarcoma/drug therapy ; Sarcoma/mortality ; Sarcoma/pathology